ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs
Bruce W. Keene(North Carolina State University), Masami Uechi(Yokohama City University Medical Center), Jens Häggström(Swedish University of Agricultural Sciences), John D. Bonagura(North Carolina State University), Virginia Luis Fuentes(Royal Veterinary College), Mark A. Oyama(University of Pennsylvania), Rebecca L. Stepien(University of Wisconsin–Madison), Clarke E. Atkins(North Carolina State University), Philip R. Fox(The Schwarzman Animal Medical Center), John E. Rush(Tufts University)
Cited by 810
Related Papers
Guidelines for the Identification, Evaluation, and Management of Systemic Hypertension in Dogs and Cats
|Journal of Veterinary Internal Medicine|2007|644
ACVIM consensus statement: Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats
|Journal of Veterinary Internal Medicine|2018|575
Guidelines for the Identification, Evaluation, and Management of Systemic Hypertension in Dogs and Cats
|Journal of Veterinary Internal Medicine|2007|559
Guidelines for the Diagnosis and Treatment of Canine Chronic Valvular Heart Disease
|Journal of Veterinary Internal Medicine|2009|545
Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study—A Randomized Clinical Trial
|Journal of Veterinary Internal Medicine|2016|318